DA414
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DA414, covering 2024-07-29 to 2024-07-29. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on DA414 [Phase 1]